Shiguang Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shiguang Li has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Lin Jiang
Department of Radiology, The Third Affiliated Hospital of Zunyi Medical University (The First People’s Hospital of Zunyi), Zunyi, China
2 shared publications- Xianchun Zeng
Department of Nuclear Medicine, Guizhou Provincial People's Hospital, Guizhou, 550002, China
2 shared publications Xin Liu
Department of Pathology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2 shared publicationsXuejin Ma
Department of Radiology, The Third Affiliated Hospital of Zunyi Medical University (The First People’s Hospital of Zunyi), Zunyi, China
2 shared publicationsXuzhu Chen
Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2 shared publicationsYan Yang
Department of Radiology, The Affiliated Jinyang Hospital of Guizhou Medical University, Guiyang, China
2 shared publications
Latest Publications
- Open Access
- 23 July 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1802360
Diagnostic performance of Kaiser score, ADC, and their combination for BI-RADS 4 breast lesions: subgroup and misclassification analysis
Background: The Kaiser score and apparent diffusion coefficient (ADC) have been proposed as diagnostic adjuncts to reduce unnecessary biopsies in Breast Imaging Reporting and Data System (BI-RADS) 4 breast lesions. However, which specific histopathologic entities are prone to misclassification by each diagnostic model remains poorly characterized, limiting clinical guidance for borderline cases. Objective: To compare the diagnostic performance of the Kaiser score, ADC, and their combination (Kaiser+) stratified by lesion morphology, and to identify histopathologic subtypes most susceptible to misclassification. Methods: This retrospective study included 222 patients with BI-RADS 4 breast lesions confirmed by histopathology. Two radiologists independently evaluated lesions using the Kaiser score and ADC values (threshold: 1.4 × 10 -3 mm²/s). Diagnostic performance was assessed using receiver operating characteristic (ROC) analysis, and misclassification patterns were analyzed by pathologic subtype using McNemar’s test with Bonferroni correction. Results: The Kaiser score achieved the highest area under the curve (AUC) of 0.901 (95% CI: 0.856–0.941), followed by Kaiser+ (AUC 0.890; 95% CI: 0.845–0.930) and ADC alone (AUC 0.733; 95% CI: 0.666–0.800; p < 0.001 vs. Kaiser). Kaiser demonstrated superior performance in mass lesions (AUC 0.926; 95% CI: 0.878–0.965) compared with non-mass enhancement (NME) (AUC 0.801; 95% CI: 0.681–0.905). Pathology-stratified analysis revealed distinct misclassification patterns: fibroadenoma, breast hyperplasia, and intraductal papilloma accounted for most FP cases, with ADC showing significantly higher FP rates (66.1%; 95% CI: 57.3%–73.9%) than Kaiser (19.8%; 95% CI: 13.7%–27.8%) or Kaiser+ (17.4%; 95% CI: 11.6%–25.1%; p in situ (DCIS) and mucinous carcinoma were the majority of frequently misclassified as FN across all models. Conclusion: The Kaiser score outperformed ADC alone in BI-RADS 4 lesions. Pathology-stratified analysis identified subtype-specific diagnostic pitfalls: benign cellular and proliferative lesions drive FP cases (especially with ADC), while low-conspicuity malignancies (DCIS, mucinous carcinoma) drive FN cases. Awareness of these patterns may guide individualized biopsy decisions in clinical practice.
- 23 July 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1802360
Open AccessDiagnostic performance of Kaiser score, ADC, and their combination for BI-RADS 4 breast lesions: subgroup and misclassification analysis
Background: The Kaiser score and apparent diffusion coefficient (ADC) have been proposed as diagnostic adjuncts to reduce unnecessary biopsies in Breast Imaging Reporting and Data System (BI-RADS) 4 breast lesions. However, which specific histopathologic entities are prone to misclassification by each diagnostic model remains poorly characterized, limiting clinical guidance for borderline cases. Objective: To compare the diagnostic performance of the Kaiser score, ADC, and their combination (Kaiser+) stratified by lesion morphology, and to identify histopathologic subtypes most susceptible to misclassification. Methods: This retrospective study included 222 patients with BI-RADS 4 breast lesions confirmed by histopathology. Two radiologists independently evaluated lesions using the Kaiser score and ADC values (threshold: 1.4 × 10 -3 mm²/s). Diagnostic performance was assessed using receiver operating characteristic (ROC) analysis, and misclassification patterns were analyzed by pathologic subtype using McNemar’s test with Bonferroni correction. Results: The Kaiser score achieved the highest area under the curve (AUC) of 0.901 (95% CI: 0.856–0.941), followed by Kaiser+ (AUC 0.890; 95% CI: 0.845–0.930) and ADC alone (AUC 0.733; 95% CI: 0.666–0.800; p < 0.001 vs. Kaiser). Kaiser demonstrated superior performance in mass lesions (AUC 0.926; 95% CI: 0.878–0.965) compared with non-mass enhancement (NME) (AUC 0.801; 95% CI: 0.681–0.905). Pathology-stratified analysis revealed distinct misclassification patterns: fibroadenoma, breast hyperplasia, and intraductal papilloma accounted for most FP cases, with ADC showing significantly higher FP rates (66.1%; 95% CI: 57.3%–73.9%) than Kaiser (19.8%; 95% CI: 13.7%–27.8%) or Kaiser+ (17.4%; 95% CI: 11.6%–25.1%; p in situ (DCIS) and mucinous carcinoma were the majority of frequently misclassified as FN across all models. Conclusion: The Kaiser score outperformed ADC alone in BI-RADS 4 lesions. Pathology-stratified analysis identified subtype-specific diagnostic pitfalls: benign cellular and proliferative lesions drive FP cases (especially with ADC), while low-conspicuity malignancies (DCIS, mucinous carcinoma) drive FN cases. Awareness of these patterns may guide individualized biopsy decisions in clinical practice.
- Open Access
- 20 June 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (25) , e42862
Research hotspots and development trends in molecular imaging of glioma (2014–2024): A bibliometric review
Background: This study aims to explore research hotspots and development trends in molecular imaging of glioma from 2014 to 2024. Methods: A total of 2957 publications indexed in the web of science core collection (WoSCC) were analyzed using bibliometric techniques. To visualize the research landscape, co-citation clustering, keyword analysis, and technological trend mapping were performed using CiteSpace and Excel. Results: Publication output peaked in 2021. Emerging research trends included the integration of radiomics and artificial intelligence and the application of novel imaging modalities such as positron emission tomography and magnetic resonance spectroscopy. Significant progress was observed in blood–brain barrier disruption techniques and the development of molecular probes, especially those targeting IDH and MGMT mutations. Conclusion: Molecular imaging has been pivotal in advancing glioma research, contributing to improved diagnostic accuracy and personalized treatment strategies. However, challenges such as clinical translation and standardization remain. Future studies should focus on integrating advanced technologies into routine clinical practice to enhance patient care.
- 20 June 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (25) , e42862
Open AccessResearch hotspots and development trends in molecular imaging of glioma (2014–2024): A bibliometric review
Background: This study aims to explore research hotspots and development trends in molecular imaging of glioma from 2014 to 2024. Methods: A total of 2957 publications indexed in the web of science core collection (WoSCC) were analyzed using bibliometric techniques. To visualize the research landscape, co-citation clustering, keyword analysis, and technological trend mapping were performed using CiteSpace and Excel. Results: Publication output peaked in 2021. Emerging research trends included the integration of radiomics and artificial intelligence and the application of novel imaging modalities such as positron emission tomography and magnetic resonance spectroscopy. Significant progress was observed in blood–brain barrier disruption techniques and the development of molecular probes, especially those targeting IDH and MGMT mutations. Conclusion: Molecular imaging has been pivotal in advancing glioma research, contributing to improved diagnostic accuracy and personalized treatment strategies. However, challenges such as clinical translation and standardization remain. Future studies should focus on integrating advanced technologies into routine clinical practice to enhance patient care.
- Open Access
- 10 February 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1411213
Progression and diagnostic challenges of desmoplastic infantile ganglioglioma in a non-infant: a case report with 5-year follow-up
Desmoplastic infantile ganglioglioma (DIG) is a rare intracranial benign tumor occurring in infants under 2 years of age. It has good biological and behavioral characteristics and occasionally has malignant characteristics, such as multiple intracranial lesions, postoperative progression or recurrence, meningeal diffusion, and metastasis. We present a non-infant with DIG who underwent tumor progression. A 16-year-old girl presented with DIG in the cerebral cistern and underwent subtotal resection. A magnetic resonance imaging (MRI) of the brain 2 years later revealed that the area of abnormal enhancement in the surgical site was approximately the same as before, and follow-up was continued. A reexamination 5 years later showed that the residual extent of the operative area was significantly larger than before and involved the right frontal and temporal lobes, considering the progression of the residual part of the tumor. This case report focuses on the occurrence of DIG and its potential malignant features, as assessed through magnetic resonance imaging.
- 10 February 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1411213
Open AccessProgression and diagnostic challenges of desmoplastic infantile ganglioglioma in a non-infant: a case report with 5-year follow-up
Desmoplastic infantile ganglioglioma (DIG) is a rare intracranial benign tumor occurring in infants under 2 years of age. It has good biological and behavioral characteristics and occasionally has malignant characteristics, such as multiple intracranial lesions, postoperative progression or recurrence, meningeal diffusion, and metastasis. We present a non-infant with DIG who underwent tumor progression. A 16-year-old girl presented with DIG in the cerebral cistern and underwent subtotal resection. A magnetic resonance imaging (MRI) of the brain 2 years later revealed that the area of abnormal enhancement in the surgical site was approximately the same as before, and follow-up was continued. A reexamination 5 years later showed that the residual extent of the operative area was significantly larger than before and involved the right frontal and temporal lobes, considering the progression of the residual part of the tumor. This case report focuses on the occurrence of DIG and its potential malignant features, as assessed through magnetic resonance imaging.
- Open Access
- 27 November 2023
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 13, 1272831
Malignant transformation of desmoplastic infantile tumors in a non-infant: a case report
Desmoplastic infantile tumors (DITs) are rare benign intracranial tumors in infants with benign biological behavior and rare malignant transformation characteristics. We present a DIT case that underwent malignant transformation and metastasis. A 6-year-old girl presented with DITs and underwent surgical resection. 12 years later, the tumor recurred and underwent surgical resection again. The pathology report confirmed the lesion to be a glioblastoma multiforme. She received adjuvant treatment. A year after the surgical operation of the lesions, she had intraspinal metastasis and underwent surgical resection again. Multiple spinal cord metastases were subsequently identified in the patient. The patient’s condition exhibited severe deterioration during the follow-up period. This case report focuses on the occurrence of DITs and their potential malignant transformation, as assessed through computed tomography and magnetic resonance imaging.
- 27 November 2023
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 13, 1272831
Open AccessMalignant transformation of desmoplastic infantile tumors in a non-infant: a case report
Desmoplastic infantile tumors (DITs) are rare benign intracranial tumors in infants with benign biological behavior and rare malignant transformation characteristics. We present a DIT case that underwent malignant transformation and metastasis. A 6-year-old girl presented with DITs and underwent surgical resection. 12 years later, the tumor recurred and underwent surgical resection again. The pathology report confirmed the lesion to be a glioblastoma multiforme. She received adjuvant treatment. A year after the surgical operation of the lesions, she had intraspinal metastasis and underwent surgical resection again. Multiple spinal cord metastases were subsequently identified in the patient. The patient’s condition exhibited severe deterioration during the follow-up period. This case report focuses on the occurrence of DITs and their potential malignant transformation, as assessed through computed tomography and magnetic resonance imaging.
- 15 June 2023
- Published by S. Karger AG in Urologia Internationalis
- Vol. 107 (7) , 747-750
A Giant Urachal Accessory Spleen: Case Report
Accessory spleen (AS) refers to single or multiple splenic tissues which appear outside the relative normal spleen position results from embryonic dysplasia similar in structure and function to the spleen. AS is frequently observed in the splenic hilus and or adjacent to the tail of pancreas, and only a few cases occurred in the pelvic cavity. We present an extremely rare AS case in urachus, which was initially considered as an urachal neoplasm revealed on CT images with big mass. However, the postoperative pathology confirmed it was an AS that had not been reported at urachal before. Urachal AS can be misdiagnosed as a tumor, so it is vital to make an accurate imaging preoperative diagnosis to avoid unnecessary biopsy and surgery.
- 15 June 2023
- Published by S. Karger AG in Urologia Internationalis
- Vol. 107 (7) , 747-750
A Giant Urachal Accessory Spleen: Case Report
Accessory spleen (AS) refers to single or multiple splenic tissues which appear outside the relative normal spleen position results from embryonic dysplasia similar in structure and function to the spleen. AS is frequently observed in the splenic hilus and or adjacent to the tail of pancreas, and only a few cases occurred in the pelvic cavity. We present an extremely rare AS case in urachus, which was initially considered as an urachal neoplasm revealed on CT images with big mass. However, the postoperative pathology confirmed it was an AS that had not been reported at urachal before. Urachal AS can be misdiagnosed as a tumor, so it is vital to make an accurate imaging preoperative diagnosis to avoid unnecessary biopsy and surgery.
- Open Access
- 1 May 2022
- Published by Taylor & Francis in Journal of Hepatocellular Carcinoma
- Vol. ume 9, 379-387
Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know?
Hepatocellular carcinoma is one of the most common malignancies globally. Recently, a newly identified histological subtype, designated as “macrotrabecular-massive hepatocellular carcinoma” (MTM-HCC), has been associated with an aggressive phenotype and has received extensive attention. MTM-HCC was a strong independent prognostic predictor of early and overall recurrence because it is closely related to tumor molecular subclass, gene mutation, carcinogenesis pathways, and immunohistochemical markers. In addition, preoperative imaging examination can potentially provide an essential clue for diagnosing MTM-HCC, intratumor necrosis or ischemia is an independent predictor for MTM-HCC on Gd-EOB-DTPA enhanced MRI or CT. Early diagnosis and appropriate treatment of MTM-HCC could prove beneficial for preventing early recurrence and could improve outcomes.
- 1 May 2022
- Published by Taylor & Francis in Journal of Hepatocellular Carcinoma
- Vol. ume 9, 379-387
Open AccessMacrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know?
Hepatocellular carcinoma is one of the most common malignancies globally. Recently, a newly identified histological subtype, designated as “macrotrabecular-massive hepatocellular carcinoma” (MTM-HCC), has been associated with an aggressive phenotype and has received extensive attention. MTM-HCC was a strong independent prognostic predictor of early and overall recurrence because it is closely related to tumor molecular subclass, gene mutation, carcinogenesis pathways, and immunohistochemical markers. In addition, preoperative imaging examination can potentially provide an essential clue for diagnosing MTM-HCC, intratumor necrosis or ischemia is an independent predictor for MTM-HCC on Gd-EOB-DTPA enhanced MRI or CT. Early diagnosis and appropriate treatment of MTM-HCC could prove beneficial for preventing early recurrence and could improve outcomes.
- Open Access
- 4 June 2021
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 11
Case Report: Solitary Extramedullary Plasmacytoma in the Cervix Misdiagnosed as Cervical Cancer
Solitary plasmacytoma (SP) is a malignant tumor caused by the monoclonal proliferation of plasma cells, representing less than 5% of plasma cell tumors. SP can be categorized into two groups: solitary bone plasmacytoma (SBP) and solitary extramedullary plasmacytoma (SEP). SEP most commonly occurs in the head and neck and is rarely located in the reproductive system. Here, we report a case of a 77-year-old woman with SEP in the cervix who had a 7-day history of vaginal bleeding. Ultrasonography and magnetic resonance imaging (MRI) showed an oval mass in the cervix, which was initially considered as neoplastic lesions and highly suspected to be cervical cancer, but cervical leiomyoma and other benign tumors cannot be completely excluded. Subsequently, cervical biopsy showed that the tumor was SEP, and then the patient underwent surgery. The postoperative pathological diagnosis was also SEP, which confirmed the radiologist’s misjudgment. In conclusion, SEP that occurs in the cervix is remarkably rare, and only nine cases have been reported in the cervix. No case reports to date have described in detail the imaging findings of cervical SEP. This study demonstrates the MRI imaging characteristics of a patient with SEP of the cervix and reviews the imaging findings of SEP reported in the previous literature, in order to provide more extensive insights for radiologists to consider the differential diagnosis of cervical lesions.
- 4 June 2021
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 11
Open AccessCase Report: Solitary Extramedullary Plasmacytoma in the Cervix Misdiagnosed as Cervical Cancer
Solitary plasmacytoma (SP) is a malignant tumor caused by the monoclonal proliferation of plasma cells, representing less than 5% of plasma cell tumors. SP can be categorized into two groups: solitary bone plasmacytoma (SBP) and solitary extramedullary plasmacytoma (SEP). SEP most commonly occurs in the head and neck and is rarely located in the reproductive system. Here, we report a case of a 77-year-old woman with SEP in the cervix who had a 7-day history of vaginal bleeding. Ultrasonography and magnetic resonance imaging (MRI) showed an oval mass in the cervix, which was initially considered as neoplastic lesions and highly suspected to be cervical cancer, but cervical leiomyoma and other benign tumors cannot be completely excluded. Subsequently, cervical biopsy showed that the tumor was SEP, and then the patient underwent surgery. The postoperative pathological diagnosis was also SEP, which confirmed the radiologist’s misjudgment. In conclusion, SEP that occurs in the cervix is remarkably rare, and only nine cases have been reported in the cervix. No case reports to date have described in detail the imaging findings of cervical SEP. This study demonstrates the MRI imaging characteristics of a patient with SEP of the cervix and reviews the imaging findings of SEP reported in the previous literature, in order to provide more extensive insights for radiologists to consider the differential diagnosis of cervical lesions.